Clincosm LogoSign in Get a demo

Hematologic Malignancies

Showing 1 - 25 of 136
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

Not yet recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023

Hematologic Malignancies Trial in Zhengzhou (RD13-02 cell infusion)

Recruiting
  • Hematologic Malignancies
  • RD13-02 cell infusion
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jun 26, 2023

Hematologic Malignancies Trial in Los Angeles (Cyclophosphamide)

Not yet recruiting
  • Hematologic Malignancies
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 5, 2023

Hematologic Malignancies, Patient Participation Trial in Istanbul (Lavander oil Aromatherapy, Saline Solution)

Recruiting
  • Hematologic Malignancies
  • Patient Participation
  • Lavander oil Aromatherapy
  • Saline Solution
  • Istanbul, Küçükçekmece, Turkey
    Dilek Yildirim
Mar 30, 2023

Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 16, 2023

    Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement

    Recruiting
    • Lymphoma
    • +4 more
    • Vysis LSI MYC Break Apart Rearrangement Probe Kit
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

    Recruiting
    • Hematologic Malignancies
    • Haplo HCT <55 years old
    • +4 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 25, 2023

    Hematologic Malignancies Trial in Shanghai (GNC-035)

    Recruiting
    • Hematologic Malignancies
    • Guiyang, Guizhou, China
    • +3 more
    Jan 13, 2023

    Hematologic Malignancies Trial in Worldwide (Nemtabrutinib)

    Recruiting
    • Hematologic Malignancies
    • Torrance, California
    • +51 more
    Jan 12, 2023

    Hematologic Malignancies Trial in Chicago, New York (device, drug, radiation)

    Recruiting
    • Hematologic Malignancies
    • CliniMACS® CD34 Reagent System
    • +7 more
    • Chicago, Illinois
    • +1 more
    Sep 20, 2022

    HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

    Not yet recruiting
    • HIV
    • Hematologic Malignancies
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Hematologic Malignancies Trial in Australia, United States (APG-2575)

    Recruiting
    • Hematologic Malignancies
    • Jacksonville, Florida
    • +4 more
    Aug 12, 2022

    Hematologic Malignancies Trial in Japan (Teclistamab)

    Recruiting
    • Hematologic Malignancies
    • Chiba, Japan
    • +14 more
    Aug 11, 2022

    Hematologic Malignancies Trial in China, United States (GFH009)

    Recruiting
    • Hematologic Malignancies
    • New Orleans, Louisiana
    • +16 more
    Aug 2, 2022

    Hematologic Malignancies Trial in Assiut (CD56)

    Recruiting
    • Hematologic Malignancies
    • CD56
    • Assiut, Egypt
    • +1 more
    Jul 20, 2022

    Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

    Suspended
    • Hematologic Malignancies
    • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
    • La Jolla, California
      UCSD Medical Center
    Jul 20, 2022

    Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)

    Terminated
    • Hematologic Malignancies
    • Aurora, Colorado
    • +16 more
    Apr 29, 2022

    Advanced Solid Tumors, Lymphoma, Multiple Myeloma Trial in Nashville, Houston (AZD0466)

    Terminated
    • Advanced Solid Tumors
    • +3 more
    • Nashville, Tennessee
    • +1 more
    Apr 22, 2022

    Hematologic Malignancies Trial in Milwaukee (CliniMACs)

    Active, not recruiting
    • Hematologic Malignancies
    • CliniMACs
    • Milwaukee, Wisconsin
      Children's Hospital of Wisconsin
    Apr 4, 2022

    Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)

    Recruiting
    • Hematologic Malignancies
    • Busulfan 3.2 mg/kg/day
    • +5 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 14, 2022

    Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)

    Recruiting
    • Hematologic Malignancies
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Feb 14, 2022

    Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem

    Active, not recruiting
    • Hematologic Malignancies
    • +7 more
    • San Francisco, California
      University of California, San Francisco
    Feb 28, 2022

    Hematologic Malignancies Trial in Hangzhou (RD13-01 cell infusion)

    Completed
    • Hematologic Malignancies
    • RD13-01 cell infusion
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital，College of Medicine, Zhejiang Univ
    Jan 8, 2022

    Hematologic Malignancies, Relapse, GVHD Trial in Ann Arbor (Carfilzomib, Tacrolimus)

    Completed
    Has Results
    • Hematologic Malignancies
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan Hospital
    Dec 3, 2021

    Hematologic Malignancies Trial in United States (ProHema-CB, Untreated CB)

    Terminated
    • Hematologic Malignancies
    • ProHema-CB
    • Untreated CB
    • Duarte, California
    • +10 more
    Nov 26, 2021